2012
DOI: 10.1016/j.niox.2012.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Hypotensive effect of Oxacom® containing a dinitrosyl iron complex with glutathione: Animal studies and clinical trials on healthy volunteers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

5
50
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 73 publications
(55 citation statements)
references
References 20 publications
5
50
0
Order By: Relevance
“…These studies showed that the toxic dose of the drug exceeds 200-fold its hypotensive dose for rats, but is 800 times lower than that for human beings. The drug did not manifest any mutagenic, allergenic, embryotoxic or teratogenic activity in the dose range under study [33]. Fig.…”
Section: Introductionmentioning
confidence: 72%
See 4 more Smart Citations
“…These studies showed that the toxic dose of the drug exceeds 200-fold its hypotensive dose for rats, but is 800 times lower than that for human beings. The drug did not manifest any mutagenic, allergenic, embryotoxic or teratogenic activity in the dose range under study [33]. Fig.…”
Section: Introductionmentioning
confidence: 72%
“…(4) shows the hypotensive effect of Oxacom on 14 healthy volunteers. A single intravenous injection of DNIC with glutathione at the dose of 0.2 µmoles/kg induced a stable 20-25% decrease of mean arterial pressure, which lasted from 6 to 8 hours and correlated with long-term persistence of DNIC in patients' blood [33].…”
Section: Introductionmentioning
confidence: 86%
See 3 more Smart Citations